Last reviewed · How we verify
NCT06945796
ACT-ED: Accessibility and Feasibility of an Acceptance and Commitment Therapy (ACT)-Based Eating Disorder Prevention Program
NA trial testing ACT based eating disorder prevention program in Eating Disorders Symptoms in 5 participants. Completed in 2 February 2025.
2 February 2025
Quick facts
| Lead sponsor | Ibn Haldun University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 5 |
| Start date | 18 November 2024 |
| Primary completion | 2 February 2025 |
| Estimated completion | 2 February 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- ACT based eating disorder prevention program
Conditions studied
- Eating Disorders Symptoms — all drugs for Eating Disorders Symptoms →
- Eating Pathology — all drugs for Eating Pathology →
- Disordered Eating Behaviors — all drugs for Disordered Eating Behaviors →
Sponsor
Ibn Haldun University
Who can join
18 and older, female only, with Eating Disorders Symptoms or Eating Pathology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to investigate the accessibility and feasibility of an online group prevention program developed for women at risk for eating disorders. Also, to conduct a preliminary analysis of treatment efficacy. The main questions it aims to answer are: Does ACT-ED an acceptable intervention for women at risk for eating disorders? Does intervention result in reduced eating pathology? Participants will: Join the online, 4-session ACT-based group program Fill the measures at Pre-test, post-test and follow-up assessment
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06945796
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Eating Disorders Symptoms
Currently open trials in the same condition.
- NCT07295197 — Oral Indicators for ED Screening · recruiting
- NCT07196189 — Effects of Fecal Microbiota Transplantation · recruiting
Other Ibn Haldun University trials
Trials by the same sponsor.
- NCT07008209 — Comparing the Effectiveness of Reappraisal Strategies in Adult Participants · NA · completed
- NCT06876103 — Effectiveness of an Online Religiously-integrated Cognitive Behavioral Therapy-based Intervention on Death Anxiety · NA · not yet recruiting
- NCT06213194 — The Effects of Executive Functions and Social Cognition on Mental Health · NA · completed
- NCT07334769 — Religiously Integrated Cognitive Behavioral Therapy · NA · completed
- NCT06758635 — Online Versions of Single Session Virtual Reality (VR) Therapy and EMDR Flash Therapy on the Treatment of Flying Fear · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06945796 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ibn Haldun University
- Last refreshed: 10 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06945796.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing